Stock Analysis on Net
Stock Analysis on Net

GlaxoSmithKline PLC (NYSE:GSK)

$22.49

This company has been moved to the archive! The financial data has not been updated since February 27, 2015.

Analysis of Equity Method Investments

Microsoft Excel

Paying users area

Try for free

GlaxoSmithKline PLC pages available for free this week:

The data is hidden behind: . Unhide it.

  • Get 1-month access to GlaxoSmithKline PLC for $22.49, or

  • get full access to the entire website for at least 3 months from $62.19.

Get access

This is a one-time payment. There is no automatic renewal.

We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Apple Pay Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Selected Financial Data

GlaxoSmithKline PLC selected financial data

US$ in millions, translated from GBP £

Microsoft Excel
Dec 31, 2014 Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Share of after tax profits of associates and joint ventures
Associated
Profitability Ratio
ROA (equity method investments only)1

Based on: 20-F (reporting date: 2014-12-31), 20-F (reporting date: 2013-12-31), 20-F (reporting date: 2012-12-31), 20-F (reporting date: 2011-12-31), 20-F (reporting date: 2010-12-31).

1 2014 Calculation
ROA (equity method investments only) = 100 × Share of after tax profits of associates and joint ventures ÷ Associated
= 100 × ÷ =

Item Description The company
Share of after tax profits of associates and joint ventures This item represents the entity proportionate share for the period of the net income (loss) of its investee (such as unconsolidated subsidiaries and joint ventures) to which the equity method of accounting is applied. Such amount typically reflects adjustments similar to those made in preparing consolidated statements, including adjustments to eliminate intercompany gains and losses, and to amortize, if appropriate, any difference between cost and underlying equity in net assets of the investee at the date of investment. GlaxoSmithKline PLC share of after tax profits of associates and joint ventures increased from 2012 to 2013 but then slightly decreased from 2013 to 2014 not reaching 2012 level.
Associated This item represents the carrying amount on the entity balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment losses recognized. GlaxoSmithKline PLC associated decreased from 2012 to 2013 but then slightly increased from 2013 to 2014.
ROA (equity method investments only) A profitability ratio calculated as share of after tax profits of associates and joint ventures divided by associated. GlaxoSmithKline PLC ROA of equity method investments improved from 2012 to 2013 but then slightly deteriorated from 2013 to 2014 not reaching 2012 level.

Summarized Financial Information

Summarized financial information for GlaxoSmithKline PLC affiliates, subsidiaries, associates, and joint ventures

US$ in millions, translated from GBP £

Microsoft Excel
Dec 31, 2014 Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total assets
Total liabilities
Equity
Total liabilities and equity
Turnover
Profit after taxation

Based on: 20-F (reporting date: 2014-12-31), 20-F (reporting date: 2013-12-31), 20-F (reporting date: 2012-12-31), 20-F (reporting date: 2011-12-31), 20-F (reporting date: 2010-12-31).

Item Description The company
Equity Amount of equity, excluding noncontrolling interest, attributable to the equity method investment of the entity. Equity of GlaxoSmithKline PLC affiliates, subsidiaries, associates, and joint ventures decreased from 2012 to 2013 but then increased from 2013 to 2014 not reaching 2012 level.
Profit after taxation The amount of net income (loss) reported by an equity method investment of the entity. Profit after taxation of GlaxoSmithKline PLC affiliates, subsidiaries, associates, and joint ventures increased from 2012 to 2013 and from 2013 to 2014.

Adjustments to Financial Statements: Proportionate Consolidation

Recognition of GlaxoSmithKline PLC proportionate share of affiliates, subsidiaries, associates, and joint ventures assets and liabilities instead of net equity.

GlaxoSmithKline PLC, adjustments to financial statements

US$ in millions, translated from GBP £

Microsoft Excel
Dec 31, 2014 Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Weighted average percentage interest in affiliates
Adjustments to Total Assets
Total assets (as reported)
Less: Associated (adjustment)
Add: Total assets of affiliates (adjustment)
Total assets (adjusted)
Adjustment to Total Liabilities
Total liabilities (as reported)
Add: Total liabilities of affiliates (adjustment)
Total liabilities (adjusted)
Adjustment to Turnover
Turnover (as reported)
Add: Turnover of affiliates (adjustment)
Turnover (adjusted)

Based on: 20-F (reporting date: 2014-12-31), 20-F (reporting date: 2013-12-31), 20-F (reporting date: 2012-12-31), 20-F (reporting date: 2011-12-31), 20-F (reporting date: 2010-12-31).

GlaxoSmithKline PLC, Financial Data: Reported vs. Adjusted

Adjusted Financial Ratios: Proportionate Consolidation (Summary)

GlaxoSmithKline PLC, adjusted financial ratios

Microsoft Excel
Dec 31, 2014 Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Net Profit Margin
Reported net profit margin
Adjusted net profit margin
Total Asset Turnover
Reported total asset turnover
Adjusted total asset turnover
Financial Leverage
Reported financial leverage
Adjusted financial leverage
Return on Assets (ROA)
Reported ROA
Adjusted ROA

Based on: 20-F (reporting date: 2014-12-31), 20-F (reporting date: 2013-12-31), 20-F (reporting date: 2012-12-31), 20-F (reporting date: 2011-12-31), 20-F (reporting date: 2010-12-31).

Financial ratio Description The company
Adjusted net profit margin An indicator of profitability, calculated as net income divided by adjusted revenue. GlaxoSmithKline PLC adjusted net profit margin ratio improved from 2012 to 2013 but then deteriorated significantly from 2013 to 2014.
Adjusted total asset turnover An activity ratio calculated as adjusted total revenue divided by adjusted total assets. GlaxoSmithKline PLC adjusted total asset turnover ratio deteriorated from 2012 to 2013 and from 2013 to 2014.
Adjusted financial leverage A measure of financial leverage calculated as adjusted total assets divided by total equity.
Financial leverage is the extent to which a company can effect, through the use of debt, a proportional change in the return on common equity that is greater than a given proportional change in operating income.		 GlaxoSmithKline PLC adjusted financial leverage ratio decreased from 2012 to 2013 but then increased from 2013 to 2014 exceeding 2012 level.
Adjusted ROA A profitability ratio calculated as net income divided by adjusted total assets. GlaxoSmithKline PLC adjusted ROA improved from 2012 to 2013 but then deteriorated significantly from 2013 to 2014.

GlaxoSmithKline PLC, Financial Ratios: Reported vs. Adjusted

Adjusted Net Profit Margin

Microsoft Excel
Dec 31, 2014 Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
As Reported
Selected Financial Data (US$ in millions, translated from GBP £)
Profit attributable to shareholders
Turnover
Profitability Ratio
Net profit margin1
Adjusted: from Equity Method to Proportionate Consolidation
Selected Financial Data (US$ in millions, translated from GBP £)
Profit attributable to shareholders
Adjusted turnover
Profitability Ratio
Adjusted net profit margin2

Based on: 20-F (reporting date: 2014-12-31), 20-F (reporting date: 2013-12-31), 20-F (reporting date: 2012-12-31), 20-F (reporting date: 2011-12-31), 20-F (reporting date: 2010-12-31).

2014 Calculations

1 Net profit margin = 100 × Profit attributable to shareholders ÷ Turnover
= 100 × ÷ =

2 Adjusted net profit margin = 100 × Profit attributable to shareholders ÷ Adjusted turnover
= 100 × ÷ =

Profitability ratio Description The company
Adjusted net profit margin An indicator of profitability, calculated as net income divided by adjusted revenue. GlaxoSmithKline PLC adjusted net profit margin ratio improved from 2012 to 2013 but then deteriorated significantly from 2013 to 2014.

Adjusted Total Asset Turnover

Microsoft Excel
Dec 31, 2014 Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
As Reported
Selected Financial Data (US$ in millions, translated from GBP £)
Turnover
Total assets
Activity Ratio
Total asset turnover1
Adjusted: from Equity Method to Proportionate Consolidation
Selected Financial Data (US$ in millions, translated from GBP £)
Adjusted turnover
Adjusted total assets
Activity Ratio
Adjusted total asset turnover2

Based on: 20-F (reporting date: 2014-12-31), 20-F (reporting date: 2013-12-31), 20-F (reporting date: 2012-12-31), 20-F (reporting date: 2011-12-31), 20-F (reporting date: 2010-12-31).

2014 Calculations

1 Total asset turnover = Turnover ÷ Total assets
= ÷ =

2 Adjusted total asset turnover = Adjusted turnover ÷ Adjusted total assets
= ÷ =

Activity ratio Description The company
Adjusted total asset turnover An activity ratio calculated as adjusted total revenue divided by adjusted total assets. GlaxoSmithKline PLC adjusted total asset turnover ratio deteriorated from 2012 to 2013 and from 2013 to 2014.

Adjusted Financial Leverage

Microsoft Excel
Dec 31, 2014 Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
As Reported
Selected Financial Data (US$ in millions, translated from GBP £)
Total assets
Shareholders’ equity
Solvency Ratio
Financial leverage1
Adjusted: from Equity Method to Proportionate Consolidation
Selected Financial Data (US$ in millions, translated from GBP £)
Adjusted total assets
Shareholders’ equity
Solvency Ratio
Adjusted financial leverage2

Based on: 20-F (reporting date: 2014-12-31), 20-F (reporting date: 2013-12-31), 20-F (reporting date: 2012-12-31), 20-F (reporting date: 2011-12-31), 20-F (reporting date: 2010-12-31).

2014 Calculations

1 Financial leverage = Total assets ÷ Shareholders’ equity
= ÷ =

2 Adjusted financial leverage = Adjusted total assets ÷ Shareholders’ equity
= ÷ =

Solvency ratio Description The company
Adjusted financial leverage A measure of financial leverage calculated as adjusted total assets divided by total equity.
Financial leverage is the extent to which a company can effect, through the use of debt, a proportional change in the return on common equity that is greater than a given proportional change in operating income.		 GlaxoSmithKline PLC adjusted financial leverage ratio decreased from 2012 to 2013 but then increased from 2013 to 2014 exceeding 2012 level.

Adjusted Return on Assets (ROA)

Microsoft Excel
Dec 31, 2014 Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
As Reported
Selected Financial Data (US$ in millions, translated from GBP £)
Profit attributable to shareholders
Total assets
Profitability Ratio
ROA1
Adjusted: from Equity Method to Proportionate Consolidation
Selected Financial Data (US$ in millions, translated from GBP £)
Profit attributable to shareholders
Adjusted total assets
Profitability Ratio
Adjusted ROA2

Based on: 20-F (reporting date: 2014-12-31), 20-F (reporting date: 2013-12-31), 20-F (reporting date: 2012-12-31), 20-F (reporting date: 2011-12-31), 20-F (reporting date: 2010-12-31).

2014 Calculations

1 ROA = 100 × Profit attributable to shareholders ÷ Total assets
= 100 × ÷ =

2 Adjusted ROA = 100 × Profit attributable to shareholders ÷ Adjusted total assets
= 100 × ÷ =

Profitability ratio Description The company
Adjusted ROA A profitability ratio calculated as net income divided by adjusted total assets. GlaxoSmithKline PLC adjusted ROA improved from 2012 to 2013 but then deteriorated significantly from 2013 to 2014.